McKay, R. R., Ballman, K. V., Atherton, P. J., Ajmera, A., Baghdadi, T. A., Baumann, B. C., Beltran, H., Berg, S., Chen, R. C., Choudhury, A. D., Cole, S., Jacene, H. A., Lang, J. M., Kilari, D., Kwok, Y., McGregor, B., Morris, M. J., Parikh, M., Swami, U., Tan, A., Yang, Y. A., Zhang, T., Galsky, M., Rosenberg, J., George, D., Choueiri, T. K. (2026). Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801). Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-01135